{"nctId":"NCT02080403","briefTitle":"The Efficacy and Safety of Chlorhexidine Gluconate Chip (PerioChip®) in Therapy of Peri-implantitis","startDateStruct":{"date":"2014-07","type":"ACTUAL"},"conditions":["Peri-Implantitis"],"count":290,"armGroups":[{"label":"Treatment","type":"EXPERIMENTAL","interventionNames":["Drug: 2.5 mg Chlorhexidine gluconate chip"]},{"label":"Control","type":"NO_INTERVENTION","interventionNames":[]}],"interventions":[{"name":"2.5 mg Chlorhexidine gluconate chip","otherNames":["PerioChip®"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Good general health\n* At least one implant in the oral cavity with clinical and radiographical signs of peri-implantitis. Including bone loss in combination with bleeding and/or suppuration on probing and a peri-implant Probing Depth (PD) of 5-8 mm.\n* The implants have been in function for more than 2 years.\n* Fixed prosthetic restoration of the implant.\n\nExclusion Criteria:\n\n* Pregnancy.\n* Patient uses Chlorhexidine oral rinses/ mouthwashes on a regular basis.\n* Allergic reaction to Chlorhexidine.\n* Active Periodontitis which required definitive treatment.\n* Presence of orthodontic appliances, or any removable appliances, that impinges on the tissues being assessed.\n* Use of systemic antibiotic therapy and/or chronically use of non-steroidal anti-inflammatory drugs (NSAIDs).\n* Uncontrolled diabetes, of any type.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Absolute Change in Mean Probing Pocket Depth for Selected Target Implants","description":"Pocket depth was measured as the distance from the coronal edge of the gingival margin to the base of the pocket. It was assessed at 4 sites per implant: mesiobuccal, midbuccal, distobuccal, and midlingual. Only one of the 4 sites, usually the deepest, was determine to be target implant.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.69","spread":"1.18"},{"groupId":"OG001","value":"-1.51","spread":"1.16"}]}]}]},{"type":"SECONDARY","title":"Absolute Change in Mean Probing Pocket Depth of Selected Target Implants in Patients With Baseline Pocket Depth Measurement of 6-8 mm Inclusive","description":"Pocket depth was measured as the distance from the coronal edge of the gingival margin to the base of the pocket. It was assessed at 4 sites per implant: mesiobuccal, midbuccal, distobuccal, and midlingual. Only one of the 4 sites, usually the deepest, was determine to be target implant.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.77","spread":"1.25"},{"groupId":"OG001","value":"-1.65","spread":"1.18"}]}]}]},{"type":"SECONDARY","title":"Percentage of Selected Target Implants Bleeding on Probing (BOP)","description":"The proportion of the change in bleeding status (bleeding to no bleeding) for the selected target implant","paramType":"COUNT_OF_UNITS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"90","spread":null},{"groupId":"OG001","value":"77","spread":null}]}]}]},{"type":"SECONDARY","title":"Precentage of Selected Target Implant BOP","description":"The proportion of change in bleeding status (bleeding to no bleeding) for selected target implant","paramType":"COUNT_OF_UNITS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"76","spread":null},{"groupId":"OG001","value":"73","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":4,"n":146},"commonTop":["Implant site pain","Nasopharyngitis","Post procedural discomfort","Tooth repair","Toothache"]}}}